相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
T. Zuberbier et al.
ALLERGY (2014)
Changing roles of eosinophils in health and disease
Glenn T. Furuta et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)
Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis
Lawrence F. Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Omalizumab, an anti-immunoglobulin E antibody: state of the art
Cristoforo Incorvaia et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
Omalizumab for the Treatment of Inadequately Controlled Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Sophia Tsabouri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial
Shuba Rajashri Iyengar et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Significantly High Levels of Anti-dsDNA Immunoglobulin E in Sera and the Ability of dsDNA to Induce the Degranulation of Basophils from Chronic Urticaria Patients
Yuko Hatada et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
Allen Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Marcus Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Omalizumab is effective in nonautoimmune urticaria
Marta Ferrer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
Sarbjit Saini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
Marcus Maurer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Behavior of Circulating CD4+CD25+Foxp3+Regulatory T Cells in Colon Cancer Patients Undergoing Surgery
Ausilia Sellitto et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
IgE Mediated Autoallergy against Thyroid Peroxidase - A Novel Pathomechanism of Chronic Spontaneous Urticaria?
Sabine Altrichter et al.
PLOS ONE (2011)
Two Cases of Severe Refractory Chronic Idiopathic Urticaria Treated with Omalizumab
Christian Vestergaard et al.
ACTA DERMATO-VENEREOLOGICA (2010)
MAINTENANCE OF REMISSION WITH LOW-DOSE OMALIZUMAB IN LONG-LASTING, REFRACTORY CHRONIC URTICARIA
Ciro Romano et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Jan L. Brozek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Off-label use of omalizumab in non-asthma conditions: new opportunities
Jaymin B Morjaria et al.
Expert Review of Respiratory Medicine (2009)
Eosinophils in Chronic Urticaria: Supporting or Leading Actors?
Riccardo Asero et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2009)
THERAPEUTIC ALTERNATIVES FOR CHRONIC URTICARIA: ADDITIONAL REPORTS ON OMALIZUMAB
Sheldon L. Spector et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Annual direct and indirect health care costs of chronic idiopathic urticaria
Laura K. DeLong et al.
ARCHIVES OF DERMATOLOGY (2008)
T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease
Francesco Boin et al.
ARTHRITIS AND RHEUMATISM (2008)
Treatment of chronic autoimmune urticaria with omalizumab
Allen P. Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults
Umberto De Fanis et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Effect of omalizumab on patients with chronic urticaria
Sheldon L. Spector et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
GATA3 up-regulation associated with surface expression of CD294/CRTH2:: a unique feature of human Th cells
Umberto De Fanis et al.
BLOOD (2007)
Th1or Th2 balance regulated by interaction between dendritic cells and NKT cells
Kazunori Ono et al.
IMMUNOLOGIC RESEARCH (2007)
Diagnostic value of tryptase in anaphylaxis and mastocytosis
Lawrence B. Schwartz
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
The role of microorganisms in atopic dermatitis
BS Baker
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Anti-IgE as a mast cell-stabilizing therapeutic agent
TW Chang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis
C Romano et al.
IMMUNOLOGY LETTERS (2005)
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
R Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival
J Kalesnikoff et al.
IMMUNITY (2001)
分享论文
